Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kalfazade N et al. - In a study to evaluate the clinical value of detected prostate-specific antigen (PSA) mRNA expression levels in circulating cells in pts with prostate cancer by qRT-PCR and determine the effect of surgical manipulation on hematogenous dissemination, it seems that highly detectable PSA mRNA expression levels in preoperative samples seem to be a significant predictable factor for prostate cancer recurrence

Methods

Results


Today in Basic Science/Genetics...keeping you current

Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas
BMC Cancer, 10/21/09

Breast cancer in the elderly: a histological assessment
Histopathology, 10/15/09

Serum calcium levels are elevated among women with untreated postmenopausal breast cancer
Cancer Causes and Control, 11/03/09

Today in Renal/Urologic...keeping you current

Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09

Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09

Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address